Veterinary Medicines

Klavuxil intramamarna suspenzija za krave u laktaciji

Authorised
  • Amoxicillin trihydrate
  • Clavulanic acid
  • Prednisolone
Download as PDF

Product identification

Medicine name:
Klavuxil intramamarna suspenzija za krave u laktaciji
Active substance:
  • Amoxicillin trihydrate
  • Clavulanic acid
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    200.00
    milligram(s)
    /
    3.00
    gram(s)
  • Clavulanic acid
    50.00
    milligram(s)
    /
    3.00
    gram(s)
  • Prednisolone
    10.00
    milligram(s)
    /
    3.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        7
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
  • Norbrook Laboratories Limited
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/12-01/595
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."